Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

ASB-9 Inhibitors

Chemicals classified as ASB-9 Inhibitors are not inhibitors in the traditional sense where a chemical compound directly binds to and inhibits a protein. Instead, these are chemicals that may indirectly impact the ankyrin repeat and SOCS box containing 9 (ASB-9) protein by modulating related signaling pathways or cellular processes. Since ASB-9 is part of a protein complex that is involved in the ubiquitination and subsequent proteasomal degradation of target proteins, inhibitors of proteasome function can indirectly affect the functional activity of ASB-9 by preventing the degradation of proteins that ASB-9 may target for ubiquitination.

Furthermore, the function of ASB-9 may also be influenced by changes in cellular signaling cascades. Certain compounds inhibit various kinases and signaling molecules like NF-κB, STAT3, JNK, PI3K, p38 MAPK, and MEK. By modulating these signaling pathways, these compounds can exert an indirect influence on the cellular processes in which ASB-9 is involved, such as protein-protein interactions and metabolic pathways. The exact influence of these compounds on ASB-9's activity depends on the cellular context and the interplay between the aforementioned signaling pathways and the ubiquitin-proteasome system.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Interferes with NF-κB signaling, which may modulate the degradation process of proteins involving SOCS box proteins like ASB-9.

Stat3 inhibitor V, stattic

19983-44-9sc-202818
sc-202818A
sc-202818B
sc-202818C
sc-202818D
sc-202818E
sc-202818F
25 mg
100 mg
250 mg
500 mg
1 g
2.5 g
5 g
$130.00
$196.00
$274.00
$512.00
$731.00
$1408.00
$2091.00
114
(3)

Inhibitor of STAT3, potentially altering SOCS protein-mediated processes, impacting ASB-9 function indirectly.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, may affect downstream effects of ASB-9 by altering JNK-related signaling.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor, may affect pathways that indirectly modulate ASB-9's role in protein turnover.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor, could alter cell signaling pathways involving ASB-9.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor, which may affect signaling pathways ASB-9 is involved in.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor, could affect the degradation of proteins that ASB-9 targets.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Specific inhibitor of the proteasome, affecting protein degradation pathways that ASB-9 may be part of.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor, could impact ASB-9's role in protein degradation.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Selective proteasome inhibitor, affects protein degradation and could influence ASB-9 activity.